Application of CD27 as a marker for distinguishing human NK cell subsets

被引:65
作者
Silva, Anabel [1 ]
Andrews, Daniel M. [1 ]
Brooks, Andrew G. [2 ]
Smyth, Mark J. [1 ]
Hayakawa, Yoshihiro [1 ]
机构
[1] Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunobiol Program, Melbourne, Vic 3002, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic, Australia
关键词
human; NK cell; subset;
D O I
10.1093/intimm/dxn022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has long been recognized that human NK cells can be divided into two phenotypically and functionally distinct subsets, based on their levels of expression of CD56. We recently found that CD27 distinguishes subsets of mature mouse NK cells. Here we report that CD27 can be used as a marker to discriminate human NK cell subsets. The majority of peripheral blood human NK cells were CD27(lo)/CD56(dim) NK cells, whereas the minor CD27(hi) NK cell population correspondingly displayed a CD56(bright) phenotype. Distinctions between CD27(lo) and CD27(hi) NK cells in their receptor expression and typical NK cell functions such as cytotoxicity and cytokine production can be easily delineated. Therefore, we propose the dual use of CD27 and CD56 as maturation/subset markers for human NK cells. The identification of CD27 subsets in both mice and humans will allow more accurate projections of the role of NK cell subsets in murine models of human pathologies where NK cells are involved.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 28 条
[1]   FUNCTIONAL CONSEQUENCES OF INTERLEUKIN-2 RECEPTOR EXPRESSION ON RESTING HUMAN-LYMPHOCYTES - IDENTIFICATION OF A NOVEL NATURAL-KILLER-CELL SUBSET WITH HIGH-AFFINITY RECEPTORS [J].
CALIGIURI, MA ;
ZMUIDZINAS, A ;
MANLEY, TJ ;
LEVINE, H ;
SMITH, KA ;
RITZ, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1509-1526
[2]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[3]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425
[4]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[5]   Acquisition of Ly49 receptor expression by developing natural killer cells [J].
Dorfman, JR ;
Raulet, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :609-618
[6]   CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2:: a potential new link between adaptive and innate immunity [J].
Fehniger, TA ;
Cooper, MA ;
Nuovo, GJ ;
Cella, M ;
Facchetti, F ;
Colonna, M ;
Caligiuri, MA .
BLOOD, 2003, 101 (08) :3052-3057
[7]   Evidence for discrete stages of human natural killer cell differentiation in vivo [J].
Freud, AG ;
Yokohama, A ;
Becknell, B ;
Lee, MT ;
Mao, HYC ;
Ferketich, AK ;
Caligiuri, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (04) :1033-1043
[8]   A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells [J].
Freud, AG ;
Becknell, B ;
Roychowdhury, S ;
Mao, HC ;
Ferketich, AK ;
Nuovo, GJ ;
Hughes, TL ;
Marburger, TB ;
Sung, J ;
Baiocchi, RA ;
Guimond, M ;
Caligiuri, MA .
IMMUNITY, 2005, 22 (03) :295-304
[9]  
Frey M, 1998, J IMMUNOL, V161, P400
[10]   Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells [J].
Grzywacz, Bartosz ;
Kataria, Nandini ;
Sikora, Magdalena ;
Oostendorp, Robert A. ;
Dzierzak, Elaine A. ;
Blazar, Bruce R. ;
Miller, Jeffrey S. ;
Verneris, Michael R. .
BLOOD, 2006, 108 (12) :3824-3833